This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Ptc Therapeutics, Inc.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Virginia D Schmith: Innovator in Deflazacort Therapy
Introduction
Virginia D Schmith is a notable inventor based in Durham, NC (US). She has made significant contributions to the field of medicine, particularly in the treatment of Duchenne muscular dystrophy (DMD). Her innovative approach to deflazacort therapy has garnered attention in the medical community.
Latest Patents
Virginia D Schmith holds 1 patent for her work titled "Methods of administering deflazacort therapy." This patent outlines a method of administering a fixed dose of deflazacort to subjects suffering from DMD. The therapy includes increasing the dosage when the subject loses ambulation or adjusting the dosage during the administration of CYP3A4 inducers or inhibitors.
Career Highlights
Virginia is currently associated with PTC Therapeutics, Inc., where she continues to advance her research and development efforts. Her work is pivotal in improving treatment options for patients with DMD, showcasing her dedication to enhancing patient care.
Collaborations
Virginia has collaborated with esteemed colleagues such as Stephen P Wanaski and Linda L Grasfeder. These partnerships have contributed to the success of her research and the development of innovative therapies.
Conclusion
Virginia D Schmith's contributions to deflazacort therapy represent a significant advancement in the treatment of Duchenne muscular dystrophy. Her innovative methods and dedication to research continue to impact the medical field positively.